PT-141
Results vary; not all of these effects have been demonstrated.
Clinical data relate to specific populations and indications.
Adverse effects are possible.
PT-141, also known as bremelanotide, is a synthetic cyclic peptide and an analogue of alpha-melanocyte-stimulating hormone (α-MSH) in the melanocortin family. Pharmacological research describes agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R receiving particular attention in central mechanisms associated with motivation and sexual response. Research has explored hypothalamic and other brain networks, including hypotheses involving dopaminergic pathway modulation, rather than direct peripheral vasodilation identical to PDE5 inhibition. The precise mechanism remains incompletely understood. A specific bremelanotide formulation is FDA-approved as Vyleesi for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder under defined conditions, but that authorization does not extend to this distinct research product. ELIX LABS PT-141 is not Vyleesi, an approved generic, or represented as equivalent or bioequivalent; its quality, safety, efficacy and bioavailability as a medicine are not established. For laboratory research use only. Not for human consumption.
Research describes agonist activity at MC1R, MC3R, MC4R and MC5R; the profile is not limited to MC4R.
MC4R is particularly studied in central mechanisms associated with motivation and sexual-response pathways.
Research has explored hypothalamic and other neural networks rather than direct peripheral vasodilation identical to PDE5 inhibition.
Dopaminergic modulation has been hypothesized in selected regions, but the precise mechanism remains incompletely understood.
Bremelanotide is a synthetic cyclic peptide and α-MSH analogue related to the melanocortin family.
Experimental pharmacology examines activity across MC1R, MC3R, MC4R and MC5R.
Research has explored hypothalamic and other networks related to motivation and sexual response.
MC4R and possible dopaminergic pathway modulation remain active, model-dependent research topics.
Approved-drug evidence does not establish this product’s quality, safety, efficacy, bioavailability or equivalence.
How to prepare your peptide safely.
PDF GuideRecommended research dosage protocols.
PDF GuideLatest clinical research and key findings.
PDF GuideSimple visual explanation of how it works.
PDF GuidePT-141, also called bremelanotide, is a cyclic peptide in the melanocortin-analogue family. It is studied for its activity at several receptors in this family.
Some research concerns melanocortin pathways involved in the nervous system and sexual response. “Central” describes this biological location; it does not mean that an effect is guaranteed in every situation.
Sildenafil is a phosphodiesterase type 5, or PDE5, inhibitor. PT-141 acts through melanocortin receptors. They therefore do not share the same mechanism and must not be presented as interchangeable products.
Both molecules are related to the α-MSH analogue family and have related structures. They remain distinct, however, and their properties and study results must be described separately.
No. A medicine’s data and conditions of use concern its authorized formulation. They do not demonstrate that a research product is equivalent or suitable for medical use.
No. A result depends on the population, outcome studied and trial conditions. It would be inaccurate to promise a general increase in libido or a consistent sexual response.
Review the analytical documentation available for the batch and confirm that it matches the reference ordered. Identity, purity and quantity are different pieces of information. A purity percentage alone does not establish sterility or the absence of endotoxins.
Follow the conditions on the label and in the batch documentation, together with your laboratory’s validated procedures. Conditions for a lyophilized powder may differ from those for a solution. Without reference-specific data, do not infer stability from another product.
No. This reference is intended for laboratory research, not human consumption or personal medical use. Scientific explanations are not prescriptions, and the quantities shown per vial are not usage doses.